Skip to content

Optimal Sensing in Atrial Tachyarrhythmia's Study

OSAT: Optimal Sensing in Atrial Tachyarrhythmia's Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01074749
Acronym
OSAT
Enrollment
111
Registered
2010-02-24
Start date
2010-07-31
Completion date
2014-07-31
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paroxysmal Atrial Fibrillation, Sick Sinus Syndrome

Keywords

AF, Automatic Mode Switch, FFRW, paroxysmal AF

Brief summary

The aim of the study is the comparison of two different leads in their capabilities to detect episodes and duration of paroxysmal atrial fibrillation (AF) and atrial tachyarrhythmia (AT), and the rejection of far field sensing of the far field R-wave (FFRW).

Detailed description

The aim of the study is the comparison of two different leads in their capabilities to detect episodes and duration of paroxysmal AF and AT and the rejection of far field sensing of the far field R-wave (FFRW). The study aims to evaluate the accuracy of the detection of atrial tachyarrhythmias (ATAs). An improved detection can potentially increase the accuracy of clinical treatment decisions, based on device derived data.

Interventions

DEVICEAccent Pacemaker

Implantation of pacemaker

Sponsors

Abbott Medical Devices
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with class I or II pacing indications for Sick Sinus Syndrome with suspected paroxysmal atrial tachyarrhythmias over the last 6 months * Signed informed consent * Age \>18 yrs

Exclusion criteria

* Severe valvular heart disease (echocardiogram less than 6 months old) * Angina Pectoris class ≥ III * Congestive heart failure - NYHA class ≥ III * Left Ventricular Ejection Fraction \< 35% (less than 6 months old) * Hypertrophic Cardiomyopathy

Design outcomes

Primary

MeasureTime frame
Number of undersensing of paroxysmal AF and AT from Holter recording.1-3 months

Secondary

MeasureTime frame
Number and duration of inappropriate mode switches due to FFRW sensing during sinus rhythm.1-3 months

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026